Both in Pharmaceuticals
MacroGenics vs Pyxis Oncology
Over the past year MGNX returned +115.4% and PYXS returned +31.8%; their daily moves had a correlation of 0.15.
MGNX +115.4% PYXS +31.8%Growth of $1, one year, split-adjusted
| Metric | MGNX | PYXS |
|---|---|---|
| Price | $3.77 | $2.90 |
| Market cap | $240.1M | $241.9M |
| Today | −7.14% | 0.00% |
| 1 month | −8.7% | −10.2% |
| 6 months | +36.6% | +128.3% |
| Year to date | +134.2% | +152.2% |
| 1 year | +117.9% | +35.5% |
| Revenue growth (YoY) | +378.0% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | 59.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.4× | 21.9× |
| Net cash | $173.3M | $33.0M |
| Dividend yield | — | — |
| Volatility (60d) | 62.8% | 128.4% |
| Short % of float | 11.4% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).